Treatment > Radioimmunotherapy


Eur J Nucl Med Mol Imaging. 2003 May; 30(5): 773-6. Epub 2003 Jan 30. (Review Article)


Reference

Radioimmunotherapy: is avidin-biotin pretargeting the preferred choice among pretargeting methods?

Paganelli G, Chinol M

Nuclear Medicine Division, European Institute of Oncology, via Ripamonti 435, 20141, Milan, Italy. direzione.mnu@ieo.it

 

PMID: 12557049 [PubMed - in process]

Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12557049&dopt=Abstract


 

HOME | Detection | Diagnosis | Epidemiology | Etiology & Pathogenesis | Integrative Medicine | Overall Mngt & Case Reports | Prevention | Prognosis | Psychosocial Aspects | Treatment 
About BrainLife
|
Children's Corner | E-mail Alerts | Journals | Newsletter | Patients & Caregivers | Search | Stem Cells | WHO Classification | SITEMAP